FDA warns of hormone patch's clotting risk
11th Nov 2005, 18:31 GMT
The Food and Drug Administration this week warned about a blood clot risk with use of Ortho McNeil's Ortho Evra contraceptive patch.
FDA warns of hormone patch's clotting risk related news:
- J&J contraceptive patch linked to risk of blood clot — Pharmaceutical Business Review Online
- FDA Issues Contraceptive Patch Warning — NPR Programs: All Things Considered
- FDA Orders Label For Contraceptive Patch — NPR Topics: Nation
- FDA Issues Warning Against J&J's Ortha Evra Birth Control Patch — Medical News Today RSS/XML Feed
- FDA Issues Warning Letters to Marketers of Unapproved Alternative Hormone Therapies — Food and Drug Administration
- Makers of birth control patch issue increased risk statement — Blogging Baby
- FDA Issues Warning for Contraceptive Patch — orlandosentinel.com News headlines
- Birth control patch 'riskier than the Pill' — the Mail online | Home
- FDA, FTC Send Warning Letters to Companies Marketing Alternative Hormone Replacement Therapies — Medical News Today RSS/XML Feed
- FDA warns over birth control patch — WFAA.com Latest News
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Lilly: Arxxant cuts sight loss in diabetes
- Merck: Arcoxia heart risk same as Voltaren
- Corcept tests psych. major depression Rx
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Dendreon seeks OK for Provenge
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries